ANALYSIS OF BIOSYNTHETIC GENE CLUSTERS OF BACILLUS PUMILUS ONU 554 IN SILICO

Authors:

Abstract
The aim of the work was an in-depth analysis of gene clusters associated with the biosynthesis of secondary metabolites (BGC) of Bacillus pumilus ONU 554 based on bioinformatics approach. Methods. Identification of species was performed with tools of TYGS server; Comprehensive Genome Analysis (CGA) Service and KmerFinder-3.2 servers; KBase was used to calculate ANI. Antibiotic resistance genes were searched through the CARD server. Analysis of the presence of gene clusters associated with the biosynthesis of secondary metabolites, bacteriocin, using antiSMASH, PRISM and Bagel4 respectively. The results. It was shown that according to the results of identification, phylogenetic analysis and DNADNA hybridization (DDH) performed in silico the Bacillus pumilus ONU 554 strain belongs to the B. pumilus group. Sequences identified as possible phages, CpG islands and CRISPR regions were found in the genome of our strain. 15 biosynthetic gene clusters (BGC) were identified using antiSMASH, PRISM and Bagel4 servers. The presence of three bacteriocin gene clusters in the genome of Bacillus pumilus ONU 554, nonribosomal peptide synthetases and combined clusters of nonribosomal peptide synthetase/polyketide synthetase type 1 were shown. Conclusions. The affiliation of Bacillus pumilus ONU 554 to the B. pumilus group was confirmed. Using updated genome analysis algorithms, a larger number of biosynthetic gene clusters (BGC) were identified. Among the clusters identified with a high degree of similarity were lichenisin (BGC0000381), bacillisin (BGC0001184), bacillibactin (BGC0002695). The fengycin (BGC0001095) and schizokinins (BGC0002683) clusters had a degree of similarity ranging from 53.0 to 60.0 %%. Updated results on the detection of CpG-islands, CRISPR regions, and antibiotic resistance genes. The obtained results indicate that the Bacillus pumilus ONU 554 strain is promising for use in the field of "Blue Biotechnology" for the development of new drugs with antimicrobial and antifungal activity.

This publication has 33 references indexed in Scilit: